Ravi P. Cholia

Research Instructor

Last publication 2022 Last refreshed 2026-04-18

faculty

7 h-index 10 pubs 327 cited

Biography and Research Information

OverviewAI-generated summary

Ravi P. Cholia's research investigates molecular mechanisms underlying glioblastoma and the therapeutic potential of phytochemicals and dietary compounds. His work has focused on the role of pyruvate kinase (PKM2) in glioblastoma multiforme and the neuroprotective effects of nicotinamide riboside. In studies on glioblastoma, Cholia has explored its cellular characteristics and potential therapeutic targets. His recent publication on nicotinamide riboside demonstrates its ability to alleviate cisplatin-induced peripheral neuropathy through SIRT2 activation. Cholia has a h-index of 7 with 10 total publications and 324 citations. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Ratan Sadhukhan, Mousumi Patra, Fen Xia, and Wuying Du.

Metrics

  • h-index: 7
  • Publications: 10
  • Citations: 327

Selected Publications

  • Nicotinamide Riboside Alleviates Cisplatin-Induced Peripheral Neuropathy via SIRT2 Activation (2022)
  • Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation (2022)
    7 citations DOI OpenAlex
  • A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme (2021)
    24 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

Collaboration Network

13 Collaborators 3 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics